ConnieWing-Ching Lee(Lee)BatleviMD

PubMed

• 17 citations
  Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma.
  Claire Roddie, Lazaros J Lekakis, Maria A V Marzolini, Aravind Ramakrishnan, Yiyun Zhang, Yanqing Hu, Vijay G R Peddareddigari, Nushmia Khokhar, Robert Chen, Silvia Ba...> ;Blood. 2023 May 18
• 3 citations
  Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma withormutations: an open label phase II study.
  David Qualls, Ariela Noy, David Straus, Matthew Matasar, Craig Moskowitz, Venkatraman Seshan, Ahmet Dogan, Gilles Salles, Anas Younes, Andrew D Zelenetz, Connie Lee Ba...> ;Leukemia & Lymphoma. 2023 Mar 1
• 11 citations
  Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell Therapy.
  Harper Hubbeling, Emily A Silverman, Laure Michaud, Ana Alarcon Tomas, Roni Shouval, Jessica Flynn, Sean Devlin, N Ari Wijetunga, Kathryn R Tringale, Connie Batlevi, P...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 6 citations
  Management of prolonged cytopenia following CAR T-cell therapy.
  Magdalena Corona, Roni Shouval, Ana Alarcón, Jessica Flynn, Sean Devlin, Connie Batlevi, Simon Mantha, Maria Lia Palomba, Michael Scordo, Gunjan Shah, Craig Sauter, Mi...> ;Bone Marrow Transplantation. 2022 Dec 1
• 13 citations
  Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma.
  Ana Alarcon Tomas, Joshua A Fein, Shalev Fried, Jessica R Flynn, Sean M Devlin, Warren B Fingrut, Theodora Anagnostou, Anna Alperovich, Nishi Shah, Ellen Fraint, Richa...> ;Leukemia. 2023 Jan 1
• 5 citations
  TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.
  Tatiana Erazo, Chiara M Evans, Daniel Zakheim, Karen L Chu, Alice Yunsi Refermat, Zahra Asgari, Xuejing Yang, Mariana Da Silva Ferreira, Sanjoy Mehta, Marco Vincenzo R...> ;Nature Communications. 2022 Sep 27
• 2 citations
  Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.
  Karthik Nath, Ana Alarcon Tomas, Jessica Flynn, Joshua A Fein, Anna Alperovich, Theodora Anagnostou, Connie Lee Batlevi, Parastoo B Dahi, Warren B Fingrut, Sergio A Gi...> ;Transplantation and Cellular Therapy. 2022 Nov 1
• 4 citations
  Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas.
  Franck Morschhauser, Gilles Salles, Connie Lee Batlevi, Hervé Tilly, Aristeidis Chaidos, Tycel Phillips, John Burke, Ari Melnick> ;Blood Reviews. 2022 Nov 1
• 60 citations
  Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.
  Robert Stuver, Gunjan L Shah, Neha S Korde, Lindsey E Roeker, Anthony R Mato, Connie L Batlevi, David J Chung, Sital Doddi, Lorenzo Falchi, Boglarka Gyurkocza, Audrey ...> ;Cancer Cell. 2022 Jun 13
• Chemotherapy-free regimens in frontline follicular lymphoma.
  Connie Lee Batlevi> ;Blood. 2022 Apr 14
• 1 citations
  The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma.
  Thaís Fischer, Andy Ni, Kurt S Bantilan, Jacob D Soumerai, Anna Alperovich, Connie Batlevi, Anas Younes, Andrew D Zelenetz> ;Leukemia & Lymphoma. 2022 Mar 1
• 3 citations
  A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma.
  David Qualls, Hiu Ying Lam, Karissa Whiting, Anita Kumar, Matthew Matasar, Colette Owens, Chelsea Nichols, James A Espeleta, Annie Qiu, Sarima Subzwari, Erin Biggar, V...> ;Blood Advances. 2022 Sep 27
• 1 citations
  Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
  Fushen Sha, Michelle Okwali, Anna Alperovich, Philip C Caron, Lorenzo Falchi, Audrey Hamilton, Paul A Hamlin, Steven M Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar,...> ;Blood Cancer Journal. 2022 Feb 10
• 39 citations
  Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.
  Roni Shouval, Ana Alarcon Tomas, Joshua A Fein, Jessica Flynn, Ettai Markovits, Shimrit Mayer, Aishat Afuye, Anna Alperovich, Theodora Anagnostou, Michal J. Besser, Co...> ;Journal of Clinical Oncology. 2021 Dec 3
• 39 citations
  Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or ...
  Jacob D. Soumerai, Anthony R. Mato, Ahmet Dogan, Venkatraman E. Seshan, Erel Joffe, Kelsey Flaherty, Jason Carter, Ephraim P. Hochberg, Jeffrey A. Barnes, Audrey Hamil...> ;The Lancet. Haematology. 2021 Dec 1
• 9 citations
  Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.
  Caitlin Stewart, Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank, Paul A. Hamlin, Matthew J. Matasar, John F. Gerecitano, Pamela Dr...> ;Clinical Cancer Research. 2021 Oct 6
• 50 citations
  Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
  Martina Pennisi, Miriam Sanchez-Escamilla, Jessica Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynne Silverberg, Connie Lee Batlevi, Renier J. Brentjens, Parstoo B Da...> ;Blood Advances. 2021 Sep 14
• 15 citations
  Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker a...
  Daniel J. Landsburg, Stefan K. Barta, Radhakrishnan Ramchandren, Connie Lee Batlevi, Swaminathan P. Iyer, Kevin R. Kelly, Ivana N. Micallef, Sonali M. Smith, Don A. St...> ;British Journal of Haematology. 2021 Aug 2
• 69 citations
  Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
  Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Samia Sohail, Alayna Santa...> ;Journal of Clinical Oncology. 2021 Jun 25
• 32 citations
  Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.
  Sabela Bobillo, Erel Joffe, David Sermer, Patrizia Mondello, Paola Ghione, Philip Caron, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Anita Kumar, Matthew J. Ma...> ;Blood Cancer Journal. 2021 Jun 16
• 26 citations
  Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
  Anita Kumar, Carla Casulo, Ranjana H. Advani, Elizabeth Budde, Paul M. Barr, Connie Lee Batlevi, Philip Caron, Louis S. Constine, S.V. Dandapani, Esther Drill, Pamela ...> ;Journal of Clinical Oncology. 2021 Apr 28
• 23 citations
  The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy
  Marta Garcia-Recio, Kitsada Wudhikarn, Martina Pennisi, Rosalia Alonso-Trillo, Jessica Flynn, Roni Shouval, Aishat Afuye, Mari Lynne Silverberg, Connie W. Batlevi, Par...> ;Transplantation and Cellular Therapy. 2021 Mar 1
• 6 citations
  Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
  Erel Joffe, Yan Leyfman, Esther Drill, Sridevi Rajeeve, Andrew D. Zelenetz, M. Lia Palomba, Craig H. Moskowitz, Carol S. Portlock, Ariela Noy, Steven M. Horwitz, John ...> ;Blood Advances. 2021 Jan 26
• 30 citations
  Clinical Characteristics and Outcomes of Extranodal Stage I Diffuse Large B Cell Lymphoma in The Rituximab-Era
  Sabela Bobillo, Erel Joffe, Jessica A. Lavery, David Sermer, Paola Ghione, Ariela Noy, Philip Caron, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Anita Kumar, M...> ;Blood. 2021 Jan 7
• 1 citations
  A closer look at tazemetostat.
  Connie Lee Batlevi> ;Clinical Advances in Hematology & Oncology. 2020 Dec 1
• Join now to see all

Abstracts/Posters

• Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax i...
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor Evolution
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
  Connie Lee Batlevi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• A Phase I First-in-Human Clinical Trial of CD19-Targeted 19-28z/4-1BBL “Armored” CAR T Cells in Patients with Relapsed or Refractory NHL and CLL Including Richter's Tr... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018